BUSM researchers part of multi-center study on cardiac amyloidosis
2012-08-13
(Press-News.org) (Boston) - Researchers at Boston University School of Medicine (BUSM) have been part of a multicenter observational study called TRACS (Transthyretin Amyloidosis Cardiac Study) to help determine the health significance of a particular gene mutation which is commonly found in Black Americans.
The gene, transthyretin (TTR) and the mutation V122I, is seen in about four percent of African Americans or roughly 1.5 million people. The mutation is strongly associated with a condition called cardiac amyloidosis - a disorder where the abnormally mutated TTR protein deposits in the heart of affected individuals, causing the heart to not pump adequately and ultimately results in death. Cardiac amyloidosis due to this mutation is seen in older people, over the age of 60 years. Cardiac amyloidosis can be also be due to genetically normal TTR as well, which occurs for unclear reasons but is strongly associated with age and male gender.
The researchers enrolled 29 patients with TTR cardiac amyloidosis due to either the V122I mutation or those with genetically normal TTR, and observed them for roughly 16 months. They found that Black patients with the mutation only survived for a median of 26 months after diagnosis, and that certain measured parameters including heart function by echocardiography, blood testing and exercise capacity fell during the study and were associated with survival. Quality of life determined by questionnaire also declined significantly. These findings currently appear online in the American Heart Journal.
"This study is important because it establishes that carriers of V122I are at increased risk of death from cardiac amyloidosis once they reach an age where the disease is expressed (generally over the age of 60)," explained lead author Frederick L. Ruberg, MD, assistant professor of medicine and radiology at BUSM. According to Ruberg these findings provide an important foundation on which future studies using new drugs can be based. "If patients on the new drug live longer or decline more slowly than those in TRACS, that would suggest a beneficial effect to treatment," he added.
INFORMATION:
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-08-13
Competitiveness amongst NBA teams is more constant throughout seasons than during the ACB basketball league (Spain), which also falls after every Olympic Games. According to a study from the University of Las Palmas de Gran Canaria, the differences could be attributed to economic and organisational reasons: in the NBA there is just one division, there is a salary cap and the weakest teams have access to good players.
The National Basketball Association (NBA) of North America and the Association of Basketball Clubs (ACB) of Spain are the best and most competitive basketball ...
2012-08-13
Tel Aviv University researchers recently uncovered a seal, measuring 15 millimetres (about a half-inch) in diameter, which depicts a human figure next to a lion at the archaeological site of Beth Shemesh, located between the Biblical cities of Zorah and Eshtaol, where Samson was born, flourished, and finally buried, according to the book of Judges. The scene engraved on the seal, the time period, and the location of the discovery all point to a probable reference to the story of Samson, the legendary heroic figure whose adventures famously included a victory in hand-to-paw ...
2012-08-13
WASHINGTON, August 13, 2012─On August 13, AERA filed an amicus curiae brief in the U.S. Supreme Court case of Fisher v. University of Texas at Austin. The association is joined by seven other scientific societies in urging the Court to consider an overwhelming body of scientific evidence relevant to the case. "AERA has a fundamental interest in the accurate presentation of social science research on these important questions of law. Quite simply, we have a responsibility to enable the Court to make its determinations based on the best scientific evidence available," ...
2012-08-13
New Rochelle, NY, August 13, 2012—Even after being frozen for 18 years, human embryos can be thawed, grown in the laboratory, and successfully induced to produce human embryonic stem (ES) cells, which represent a valuable resource for drug screening and medical research. Prolonged embryonic cryopreservation as an alternative source of ES cells is the focus of an article in BioResearch Open Access, a new bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc. The article is available free online at the BioResearch Open Access website.
Kamthorn Pruksananonda ...
2012-08-13
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
Latrepirdine was initially sold as an antihistamine in Russia, following its approval for use there in 1983. In the 1990s, ...
2012-08-13
PHILADELPHIA -- A popular class of diabetes drugs increases patients' risk of bladder cancer, according to a new study published online this month in the Journal of the National Cancer Institute. Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking thiazolidinedione (TZDs) drugs – which account for up to 20 percent of the drugs prescribed to diabetics in the United States -- are two to three times more likely to develop bladder cancer than those who took a sulfonylurea drug, another common class of medications for ...
2012-08-13
Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave the way for a new class of drugs to help treat this devastating mental illness, which impacts one percent of the world's population, 30 percent of whom do not respond to currently available treatments.
A team of researchers at Mount Sinai School of Medicine set out to discover what epigenetic factors, or external factors that influence gene expression, are involved in ...
2012-08-13
Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies.
The study focused on a subtype of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-like ALL (Ph-like ALL). This subgroup accounts for as much as 15 percent of childhood ALL that is associated with a high risk of relapse and a poor outcome. The genetic changes driving the disease were previously unknown for about half of all patients with Ph-like ALL. The work identified ...
2012-08-13
The average temperatures of the atmosphere are rising; the average temperatures of the oceans, too. Not only living organisms react sensititvely to these changes. The transitional zones between shallow shelf seas and the deep sea at continental slopes store a huge amount of methane hydrates in the sea bed. These specific, ice-like compounds only forms at low temperatures and under high pressure. When the water temperature directly above the sea bed rises, some of the methane hydrates could dissolve and release the previously bound methane. "This scenario incorporates two ...
2012-08-13
In a new study, UT Dallas researchers outline how they used fluorescent molecules to "tag" DNA and monitor a process called DNA looping, a natural biological mechanism involved in rearranging genetic material in some types of cells.
The UT Dallas "tag and track" method not only sheds light on how DNA loops form, but also might be adapted to screen drugs for effectiveness against certain viruses that shuffle genetic material, such as HIV.
Until now, scientists primarily had "snapshots" of the initial and final stages of DNA loop formation, with only limited information ...
LAST 30 PRESS RELEASES:
[Press-News.org] BUSM researchers part of multi-center study on cardiac amyloidosis
